🟢 90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

ℹ️ Contains proprietary blend — exact ingredient amounts not disclosed

Label Data

2 Caplet(s) Serving Size
120 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Proprietary Blend (Herb/Botanical)
1110 mg

Other Ingredients

Microcrystalline Cellulose Magnesium Stearate Polyvinylpyrrolidone Hydroxy Propyl Methyl Cellulose Corn Starch Carboxypolymethylene Silicon Dioxide Propylene Glycol

Label Claims — Verification

All Other
Structure/Function

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Use: Take two caplets two times daily with water or as directed by a health care professional.

⚠️ Warnings & Precautions

Precautions/Warnings: Do not use if bottle seal is missing, torn or damaged.

If you are pregnant, nursing, taking any medication or have a medical condition, consult your healthcare practitioner before taking any dietary supplement.

Keep out of reach of children.

🧪 Formulation Notes

Sustained release composition of NiLitis is free from glucosamine and contains patented Curcumin C3 Complex, Boswellin (AKBBA 40%) and Ginger Extract.

Curcumin C3 Complex

Boswellin BioPerine

Additional Information

Sustained release facilitates better absorption of nutrients as they metabolize even as they are being released slowly.

Store in a cool place.

Product Details

UPC / SKU 7 67382 03344 5
DSLD Entry Date 2017-12-22
Product Type Botanical
Form Other (e.g. tea bag)
DSLD ID 81895
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.